SEC Form 4 · accession 0001140361-16-061577
Raptor Pharmaceutical Corp · RPTP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Anthony Gregg Lapointe
Director
Period of report
Apr 15, 2016
Accepted (ET)
Apr 19, 2016 · 6:45 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001070698
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Apr 15, 2016 | A | 2,092 | $0.00 | A | 2,092 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock options (right to buy)F2 | $5.22 | Apr 15, 2016 | A | 7,915 | A | — | Apr 15, 2026 | Common Stock | 7,915 | 7,915 | D |
Explanation of responses
- F1Restricted Stock Units ("RSUs"). The Reporting Person is entitled to one (1) share of common stock for each one (1) RSU upon the vesting thereof.
- F2Stock options and RSUs vest fully immediately prior to the Company's 2016 Annual Meeting of Stockholders.